Endymed Statistics

Total Valuation

Endymed has a market cap or net worth of ILS 39.92 million. The enterprise value is 16.52 million.

Market Cap	39.92M
Enterprise Value	16.52M

Important Dates

The next estimated earnings date is Thursday, November 21, 2024.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	n/a

Share Statistics

Endymed has 13.76 million shares outstanding. The number of shares has increased by 0.09% in one year.

Current Share Class	n/a
Shares Outstanding	13.76M
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	-2.95%
Owned by Insiders (%)	9.45%
Owned by Institutions (%)	0.66%
Float	5.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.54
PB Ratio	0.71
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.25
EV / Sales	0.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.34

Financial Position

The company has a current ratio of 4.49, with a Debt / Equity ratio of 0.08.

Current Ratio	4.49
Quick Ratio	2.75
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.35
Interest Coverage	-14.75

Financial Efficiency

Return on equity (ROE) is -5.53% and return on invested capital (ROIC) is -4.15%.

Return on Equity (ROE)	-5.53%
Return on Assets (ROA)	-3.28%
Return on Capital (ROIC)	-4.15%
Revenue Per Employee	1.60M
Profits Per Employee	-68,345
Employee Count	46
Asset Turnover	0.96
Inventory Turnover	1.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.28% in the last 52 weeks. The beta is -0.34, so Endymed's price volatility has been lower than the market average.

Beta (5Y)	-0.34
52-Week Price Change	-12.28%
50-Day Moving Average	230.10
200-Day Moving Average	287.05
Relative Strength Index (RSI)	66.49
Average Volume (20 Days)	33,014

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Endymed had revenue of ILS 73.81 million and -3.14 million in losses. Loss per share was -0.23.

Revenue	73.81M
Gross Profit	36.25M
Operating Income	-4.06M
Pretax Income	-3.77M
Net Income	-3.14M
EBITDA	-3.54M
EBIT	-4.06M
Loss Per Share	-0.23

Full Income Statement

Balance Sheet

The company has 27.71 million in cash and 4.31 million in debt, giving a net cash position of 23.41 million or 1.70 per share.

Cash & Cash Equivalents	27.71M
Total Debt	4.31M
Net Cash	23.41M
Net Cash Per Share	1.70
Equity (Book Value)	55.24M
Book Value Per Share	4.11
Working Capital	48.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.07 million and capital expenditures -282,383, giving a free cash flow of -12.36 million.

Operating Cash Flow	-12.07M
Capital Expenditures	-282,383
Free Cash Flow	-12.36M
FCF Per Share	-0.90

Full Cash Flow Statement

Margins

Gross margin is 49.11%, with operating and profit margins of -5.49% and -4.26%.

Gross Margin	49.11%
Operating Margin	-5.49%
Pretax Margin	-5.11%
Profit Margin	-4.26%
EBITDA Margin	-4.79%
EBIT Margin	-5.49%
FCF Margin	-16.74%

Dividends & Yields

Endymed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.09%
Shareholder Yield	-0.09%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on January 28, 2018. It was a reverse split with a ratio of 0.05.

Last Split Date	Jan 28, 2018
Split Type	Reverse
Split Ratio	0.05

Scores

Endymed has an Altman Z-Score of 2.7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.7
Piotroski F-Score	n/a